Risk of Breast Cancer by Type of Menopausal Hormone Therapy: a Case-Control Study among Post-Menopausal Women in France

BACKGROUND: There is extensive epidemiological evidence that menopausal hormone therapy (MHT) increases breast cancer risk, particularly combinations of estrogen and progestagen (EP). We investigated the effects of the specific formulations and types of therapies used by French women. Progestagen co...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordina-Duverger, Emilie, Truong, Thérèse, Anger, Antoinette, Sanchez, Marie, Arveux, Patrick, Kerbrat, Pierre, Guénel, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815310/
https://www.ncbi.nlm.nih.gov/pubmed/24223752
http://dx.doi.org/10.1371/journal.pone.0078016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815310/
https://www.ncbi.nlm.nih.gov/pubmed/24223752
http://dx.doi.org/10.1371/journal.pone.0078016

Ejemplares similares